Suicide Warning Suits Pre-Empted; Makers of Paxil, Zoloft Win

In a significant victory for drug manufacturers, the 3rd Circuit has ruled that the makers of Paxil and Zoloft cannot be sued for failing to warn of a risk of suicide because the Food and Drug Administration has explicitly refused to order such warnings. Voting 2-1 in a pair of cases where the lower courts issued conflicting rulings, the 3rd Circuit found that such lawsuits must be pre-empted because they directly conflict with action already taken by the FDA.

This article requires premium access

This article requires premium access to Law.com. Please sign in or subscribe to read the full text.